Cargando…
Inhibition of colon cancer K-Ras(G13D) mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway
K-Ras is a well-studied oncogene, and its mutation is frequently found in epithelial cancers like pancreas, lung, and colorectal cancers. Cancer cells harboring K-Ras mutations are difficult to treat due to the drug resistance and metastasis properties. Cancer stem cells (CSCs) are believed the majo...
Autores principales: | Qi, Yan, Zou, Hong, Zhao, XiaoHui, Kapeleris, Joanna, Monteiro, Michael, Li, Feng, Xu, Zhi Ping, Deng, Yizhen, Wu, Yanheng, Tang, Ying, Gu, Wenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650442/ https://www.ncbi.nlm.nih.gov/pubmed/36386200 http://dx.doi.org/10.3389/fphar.2022.996053 |
Ejemplares similares
-
Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice
por: Morella, Ilaria, et al.
Publicado: (2022) -
RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
por: Herrero, Ana, et al.
Publicado: (2021) -
Coexistence of K-ras mutations and HPV infection in colon cancer
por: Buyru, Nur, et al.
Publicado: (2006) -
Design, Synthesis, and Antileukemic Evaluation of a Novel Mikanolide Derivative Through the Ras/Raf/MEK/ERK Pathway
por: Rao, Qing, et al.
Publicado: (2022) -
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)